HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Simultaneous superficial temporal artery to middle cerebral or anterior cerebral artery bypass with pan-synangiosis for Moyamoya disease covering both anterior and middle cerebral artery territories.

Abstract
Some patients with moyamoya disease treated by conventional surgical procedures may develop postoperative refractory ischemia and perioperative cerebral infarction in the anterior cerebral artery (ACA) territory. We present a novel operative procedure for moyamoya disease to avoid the risk of ischemia in the ACA territory, which consists of simultaneous superficial temporal artery (STA) to middle cerebral artery (MCA) or ACA bypass with pan-synangiosis, encephalo-duro-arterio-myo-synangiosis for the lateral frontal and temporal areas, and encephalo-galeo-arterio-synangiosis for the medial frontal area. This procedure can establish direct bypass to the ACA territory at the first intervention. Simultaneous STA-MCA and STA-ACA bypasses with pan-synangiosis is suitable for patients with moyamoya disease associated with severely impaired perfusion of the ACA territory requiring direct bypass surgery.
AuthorsTatsuya Ishikawa, Hiroyasu Kamiyama, Satoshi Kuroda, Hiroshi Yasuda, Naoki Nakayama, Katsumi Takizawa
JournalNeurologia medico-chirurgica (Neurol Med Chir (Tokyo)) Vol. 46 Issue 9 Pg. 462-8 (Sep 2006) ISSN: 0470-8105 [Print] Japan
PMID16998283 (Publication Type: Case Reports, Journal Article)
Topics
  • Adolescent
  • Adult
  • Cerebral Revascularization (methods)
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Male
  • Middle Aged
  • Moyamoya Disease (diagnostic imaging, pathology, surgery)
  • Radiography
  • Retrospective Studies
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: